MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04830cam a22004694a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
14139591 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20170502104004.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
051011s2005 nyua b 101 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2005029699 |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
101259223 |
| Source |
DNLM |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1573316083 (cloth : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781573316088 (cloth : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1573316091 (pbk. : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781573316095 (pbk. : alk. paper) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocm62078287 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)62078287 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
NLM |
| -- |
BAKER |
| -- |
C#P |
| -- |
NLGGC |
| -- |
BTCTA |
| -- |
LVB |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
Q11 |
| Item number |
.N5 vol. 1058 |
| Classification number |
QP625.O47 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.31 |
| Edition number |
22 |
| 084 ## - OTHER CLASSIFICATION NUMBER |
|---|
| Classification number |
44.38 |
| Source of number |
bcl |
| 111 2# - MAIN ENTRY--MEETING NAME |
|---|
| Meeting name or jurisdiction name as entry element |
NIH Symposium on Therapeutic Oligonucleotides |
| Number of part/section/meeting |
(7th : |
| Date of meeting |
2004 : |
| Location of meeting |
National Institutes of Health) |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Therapeutic oligonucleotides : |
| Remainder of title |
transcriptional and translational strategies for silencing gene expression / |
| Statement of responsibility, etc |
edited by Y.S. Cho-Chung, Alan M. Gewirtz, and Cy A. Stein. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
New York Academy of Sciences, |
| Date of publication, distribution, etc |
2005. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 266 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Annals of the New York Academy of Sciences, |
| International Standard Serial Number |
0077-8923 ; |
| Volume number/sequential designation |
v. 1058 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Knockdown of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancers / Martin Gleave -- Recognition of chromosomal DNA in human cells by peptide nucleic acids and small duplex RNAs / David R. Corey -- Design and development of thermolytic DNA oligonucleotide prodrugs / Andrzej Grajkowski ... [et al.] -- Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system / J. B. Opalinska and A. M. Gewirtz -- In vivo potentialities of EWS-Fli-1 targeted antisense oligonucleotides-nanospheres complexes / Andrei Maksimenko ... [et al.] -- Endo-porter: a novel reagent for safe, effective delivery of substances into cells / James E. Summerton -- Tumor reversion: protein kinase a isozyme switching / Yoon S. Cho-Chung and Maria V. Nesterova -- Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifs / Dennis M. Klinman ... [et al.] -- Breaking tolerance to tumors with dendritic cell-based immunotherapy / Ines Mende and Edgar G. Engleman -- |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Development of resistance to RNAi in mammalian cells / Zhi-Ming Zheng, Shuang Tang, and Mingfang Tao -- The development of bioactive triple helix-forming oligonucleotides / Michael M. Seidman ... [et al.] -- Transcription factor decoys: a new model for disease intervention / Michael J. Mann -- DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their succesful [sic] delivery into cell nuclei / Irina V. Panyutin -- Targeted genome modification via triple helix formation / Jennifer M. Kalish and Peter M. Glazer -- "Promoter array" studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells / Yipeng Wang ... [et al.] -- Application of expression genomics for predicting treatment response in cancer / Khew-Voon Chin ... [et al.] -- Stability regulation of mRNA and the control of gene expression / Chris Cheadle ... [et al.] -- Novel MDM2 p53-independent functions identified through RNA silencing technologies / Zhuo Zhang ... [et al.] -- Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM 640 / Eric C. Lacasse ... [et al.] -- Induction of apoptosis by G3139 in melanoma cells / Luba Benimetskaya ... [et al.] -- Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy / Victor E. Marquez ... [et al.] -- Chemoprevention with protein kinase A RI[alpha] antisense in DMBA-mammary carcinogenesis / Maria V. Nesterova and Yoon S. Cho-chung. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Oligonucleotides |
| General subdivision |
Therapeutic use |
| Form subdivision |
Congresses. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Oligonucleotides |
| General subdivision |
therapeutic use |
| Form subdivision |
Congresses. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cho-Chung, Yoon S. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gewirtz, A. M. |
| Fuller form of name |
(Alan M.) |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Stein, Cy A. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
New York Academy of Sciences. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of contents |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip061/2005029699.html">http://www.loc.gov/catdir/toc/ecip061/2005029699.html</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0803/2005029699-d.html">http://www.loc.gov/catdir/enhancements/fy0803/2005029699-d.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Item type |
Books |
